EGFR and cancer: Alternatively, exogenous loading can also be achieved by covalently attaching the cargo proteins to the EV, such as conjugating an anti-EGFR peptide to facilitate the accumulation of EVs in EGFR-positive cancer cells, although this approach also has its limitations [99].